Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1257, 2000-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Public Citizen wants Avandia ban
Reactions Weekly, Vol. 1, Iss. 1227, 2008-01 ,pp. :
Access to resources
Recommend
The US Public Citizen group has requested that the FDA remove leflunomide [`Arava']
Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. :
A US FDA advisory committee recommends that alosetron [`Lotronex'; GlaxoSmithKline] be reintroduced
Inpharma, Vol. 1, Iss. 1336, 2002-01 ,pp. :
Oral sodium phosphates: US FDA wants new safety measures
Reactions Weekly, Vol. 1, Iss. 1233, 2009-01 ,pp. :
Erythromycin-resistant group A streptococci in the US
Inpharma, Vol. 1, Iss. 1335, 2002-01 ,pp. :